Benchmark analyst Mark Miller raised the firm’s price target on Axcelis to $215 from $146 and keeps a Buy rating on the shares. The company reported Q2 upside and guided to higher sales in the September quarter, notes the analyst, who forecasts earnings growing 14% year-over-year in 2024 to $8.03 per diluted share as a recovery in memory capex is expected to begin in the second half of next year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACLS: